A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults-Reference-Cited by-同舟云学术

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults

Published:2015-05-11 Issue:5 Volume:10 Page:e0125954
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Omosa-Manyonyi Gloria,Mpendo Juliet,Ruzagira Eugene,Kilembe William,Chomba Elwyn,Roman François,Bourguignon Patricia,Koutsoukos Marguerite,Collard Alix,Voss Gerald,Laufer Dagna,Stevens Gwynn,Hayes Peter,Clark Lorna,Cormier Emmanuel,Dally Len,Barin Burc,Ackland Jim,Syvertsen Kristen,Zachariah Devika,Anas Kamaal,Sayeed Eddy,Lombardo Angela,Gilmour Jill,Cox Josephine,Fast Patricia,Priddy Frances

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference61 articles.

1. CD8(+) T cells in preventing HIV infection and disease;AB McDermott;AIDS,2012

2. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome;RA Koup;J Virol,1994

3. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype;A Saez-Cirion;Proceedings of the National Academy of Sciences of the United States of America,2007

4. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses;A Saez-Cirion;J Immunol,2009

5. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes;JE Schmitz;Science,1999

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New-age vaccine adjuvants, their development, and future perspective;Frontiers in Immunology;2023-02-24

2. 2022 World AIDS day: Past achievements and future optimism;New Microbes and New Infections;2023-01

3. Seroprevalence of neutralizing antibodies against adenovirus type 26 and 35 in healthy populations from Guangdong and Shandong provinces, China;Virologica Sinica;2022-10

4. Induction of food-specific IgG by Gene Gun-delivered DNA vaccines;Frontiers in Allergy;2022-09-19

5. The use of adenoviral vectors in gene therapy and vaccine approaches;Genetics and Molecular Biology;2022